Spiriva vs. Ventolin

See how Spiriva and Ventolin compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Spiriva is a once-daily maintenance inhaler for COPD and asthma, while Ventolin is a fast-acting rescue inhaler for sudden bronchospasm.

  • Spiriva is not for emergency symptom relief, so patients still need a rescue inhaler like Ventolin on hand for flare-ups.

  • Ventolin typically costs far less per month than Spiriva, though insurance coverage can change the real out-of-pocket price for either.

Spiriva vs. Ventolin Drug Summary

Spiriva

Spiriva is a long-acting muscarinic antagonist (LAMA) inhaler used for daily maintenance treatment of COPD and, in its Respimat form, asthma in patients 6 and older. It comes as a once-daily inhaled powder (HandiHaler) or spray mist (Respimat) and is not meant for sudden symptom relief.

Ventolin

Ventolin is a short-acting beta2-agonist (SABA) inhaler used as a rescue treatment for sudden bronchospasm and to prevent exercise-induced asthma symptoms in patients age 4 and older. It is inhaled as needed through a metered-dose HFA inhaler and works within minutes to open the airways.

Spiriva vs. Ventolin Side Effects

Spiriva

Most common
pharyngitis (up to 12.5%)
sinusitis (up to 6.5%)
headache (up to 5.7%)
constipation (up to 5.1%)

Ventolin

Most common
throat irritation (up to 10%)
viral respiratory infections (up to 7%)
upper respiratory inflammation (up to 5%)
cough (up to 5%)

Spiriva vs. Ventolin Dosage

Spiriva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2.5 mcg once daily At the start
Maximum dose 18 mcg once daily If needed
Dose changes 2 increases As tolerated

Ventolin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2 inhalations every 4-6 hrs At the start
Maximum dose 2 inhalations pre-exercise If needed
Dose changes 2 increases As tolerated

Spiriva vs. Ventolin Indications

Spiriva

Spiriva is FDA-approved for long-term maintenance treatment of COPD, including chronic bronchitis and emphysema, and for reducing COPD exacerbations. Its Respimat device is also approved for asthma maintenance in patients 6 years and older. It is not approved for relief of sudden bronchospasm.

  • Long-term COPD maintenance treatment

  • Reduces COPD exacerbations

  • Asthma maintenance (Respimat, ages 6+)

  • Not for acute symptom relief

Ventolin

Ventolin is FDA-approved to treat or prevent bronchospasm in patients 4 years and older with reversible obstructive airway disease, such as asthma. It is also approved to prevent bronchospasm triggered by exercise. It is not approved for use in children under 4.

  • Treats and prevents bronchospasm

  • Prevents exercise-induced bronchospasm

  • Approved for ages 4 and up

  • Fast-acting rescue relief

Spiriva vs. Ventolin Pros and Cons

Spiriva

Spiriva offers steady, once-daily control of COPD and asthma symptoms rather than immediate relief, with a long track record of use since 2004. Because it works slowly and lasts all day, it is meant to be paired with a rescue inhaler for sudden symptoms, not used alone.

Pros

  • Long-acting, once-daily dosing

  • Reduces frequency of COPD exacerbations

  • Two devices cover different age groups

  • Approved for both COPD and asthma maintenance

Cons

  • Not effective for sudden symptoms

  • Higher monthly cost, roughly $600 to $630 without insurance

  • Slower onset, unsuitable for emergencies

  • Can worsen glaucoma or urinary retention

Ventolin

Ventolin acts within minutes to relieve acute bronchospasm, making it a standard rescue inhaler for asthma and COPD flare-ups. Because its effects wear off in a few hours, it is not intended for long-term daily control on its own.

Pros

  • Fast onset for rescue relief

  • Lower monthly cost, roughly $28 to $45 per inhaler without insurance

  • Approved to prevent exercise-induced bronchospasm

  • Widely used with decades of clinical history

Cons

  • Short duration requires frequent dosing

  • Not a substitute for long-term control therapy

  • Overuse linked to cardiovascular side effects

  • Not approved for children under age 4

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.